Palisade Bio (PALI) FCF Margin Growth (3y) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2020 | -6.11 Mn |
| Sep 30, 2020 | 9.82 Mn |
| Jun 30, 2020 | 10.79 Mn |
| Mar 31, 2020 | 14.96 Mn |
| Dec 31, 2019 | -3.53 Mn |
| Sep 30, 2019 | 10.31 Mn |
| Jun 30, 2019 | 12.54 Mn |
| Mar 31, 2019 | 7.35 Mn |
| Dec 31, 2018 | 9.16 Mn |
| Sep 30, 2018 | 15.51 Mn |
| Jun 30, 2018 | 19.44 Mn |
| Mar 31, 2018 | 8.85 Mn |
| Dec 31, 2017 | 7.44 Mn |
| Sep 30, 2017 | -7.04 Mn |
| Jun 30, 2017 | -8.59 Mn |
| Mar 31, 2017 | -10.97 Mn |
| Dec 31, 2016 | 5.26 Mn |
| Sep 30, 2016 | -8.48 Mn |
| Jun 30, 2016 | -1.17 Mn |
| Mar 31, 2016 | -13.77 Mn |
| Dec 31, 2015 | -5.68 Mn |
| Sep 30, 2015 | -22.08 Mn |
| Jun 30, 2015 | -19.22 Mn |
| Mar 31, 2015 | -16.10 Mn |
| Dec 31, 2014 | -7.47 Mn |
| Sep 30, 2014 | -6.08 Mn |